36
19
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21469 |
Cyclopenthiazide
Cyclomethiazide,Su-8341,SU 8341,环戊噻嗪 |
Others | Others |
Cyclopenthiazide (Cyclomethiazide) 是一种噻嗪类利尿剂,用于治疗高血压和心力衰竭。减少钙离子和尿酸的排泄,增加钠和钾离子的排泄。 | |||
T66155 |
EDTA, Disodium Salt, Dihydrate
Ethylenediaminetetraacetic acid disodium dihydrate |
Protease | Proteases/Proteasome |
EDTA, Disodium Salt, Dihydrate (Ethylenediaminetetraacetic acid disodium dihydrate) 是一种金属离子螯合剂,用作蛋白酶抑制剂。EDTA, Disodium Salt, Dihydrate 是一种对纤维素酶活性无效的分子,广泛用于蛋白质纯化。EDTA, Disodium Salt, Dihydrate 通过与金属结合,促进其排泄。 | |||
T73718 |
MDCG sodium
NOX 100 sodium,N-methyl-N-dithiocarboxyglucamine sodium |
Endogenous Metabolite | Metabolism |
MDCG sodium (N-methyl-N-dithiocarboxyglucamine sodium) 是一种金属螯合剂,可促进Cd的胆道排泄。 | |||
T5987 |
Potassium oxonate
Oxonic Acid (potassium salt),氧嗪酸钾,Potassium otastat,Potassium azaorotate |
Others | Others |
Potassium oxonate (Potassium azaorotate) 是用作尿酸酶抑制剂,都5-FU 磷酸化为5-fluorouridine-5'-monophosphate 具有抑制作用。 | |||
T23535L |
Xanthine amine congener trihydrochloride
Xanthine amine congener trihydrochloride (96865-92-8 Free base) |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
Xanthine amine congener trihydrochloride 是一种有效的腺苷拮抗剂,可逆转由腺苷激动剂 N6-环己基腺苷产生的尿流量、钠排泄和心率的减少。 | |||
T0594 |
Diphenmanil methylsulfate
Diphemanil mesylate,Diphemanil Methylsulfate,甲硫二苯马尼 |
AChR | Neuroscience |
Diphenmanil methylsulfate (Diphemanil mesylate) 是一种抗胆碱能季铵盐,可与毒蕈碱乙酰胆碱受体结合,从而减少胃酸、汗液和唾液的分泌。 | |||
T16471 |
Perflubron
Perfluorooctyl bromide,全氟溴辛烷,PFOB |
Others | Others |
Perflubron (Perfluorooctyl bromide) 是一种用于磁共振成像和超声检查的造影剂,可以与卵磷脂(EYP)一起乳化,并表现出较迅速的排泄特性。 | |||
T21302 |
UNC569
UNC 569 |
TAM Receptor | Tyrosine Kinase/Adaptors |
UNC569 (UNC 569) 是一种ATP 竞争性的、可逆、具有口服活性的Mer 激酶抑制剂,其IC50=2.9 nM,Ki=4.3 nM。它还抑制Axl 和Tyro3,IC50分别为 37 nM 和 48 nM。它可用于研究急性淋巴细胞白血病和非典型畸胎瘤/横纹肌瘤。 | |||
T14835 |
BTRX-335140
CYM-53093 |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
BTRX-335140 (CYM-53093) 是一种有效的选择性口服活性 κ 阿片受体 (KOR) 拮抗剂,对 κOR、μOR 和 δOR 具有拮抗活性,IC50 值分别为 0.8、110 和 6500 nM。它可以很好地分布到 CNS 中,在大鼠中具有良好的体外吸收、分布、代谢、排泄和毒性以及体内药代动力学特征。 | |||
T0983L |
DL-Penicillamine
3-Sulfanylvaline,DL-青霉胺 |
Antibiotic | Microbiology/Virology |
DL-Penicillamine (3-Sulfanylvaline) 是一种螯合剂,推荐用于去除威尔逊病患者体内多余的铜。 它仅存在于使用或服用该药物的个体中。它是青霉素类抗生素最具特征的降解产物。它被用作抗风湿药和威尔逊病的螯合剂。 | |||
T30242 |
AY 31906
AY-31,906 |
||
AY 31906 is a high ceiling diuretic with a relative potassium-sparing effect. AY 31906 has been shown to produce significant increases in the fractional excretion of sodium and chloride in dogs at a dose that produces no statistically significant changes | |||
T35842 |
5-chloro Hydrochlorothiazide
|
||
5-chloro Hydrochlorothiazide is a derivative of hydrochlorothiazide, which is a diuretic and antihypertensive agent that increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms. | |||
T68009 |
prorenoate
|
||
Prorenoate 是一种甾体醛固酮拮抗剂,具有保钾利尿作用。Prorenoate 可拮抗醛固酮在肾元中盐皮质激素受体的活性,从而阻止钠的重吸收。这会干扰钠/钾交换器,导致钠和水排泄,同时减少钾排泄。 | |||
T33441 |
MK789
MK 789,MK-789 |
||
MK-789 is an inhibitor of dehydropeptidase I. MK-789 and MK-791 alter the renal excretion of N-formimidoyl thienamycin from glomerular filtration plus tubular secretion to glomerular filtration only, possibly by competitively inhibiting the penetration of | |||
T33716 |
Norathiol
NOX-100,NOX100,NOX 100 |
Endogenous Metabolite | Metabolism |
Norathiol (N-methyl-N-dithiocarboxyglucamine) 是一种镉中毒解毒剂,也是一种金属螯合剂,可促进 109Cd 的排泄,可以用于治疗镉中毒。 | |||
T39274 | Lumasiran sodium | ||
Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, targets glycolate oxidase to reduce hepatic oxalate production, thereby reducing urinary oxalate excretion. This compound shows promise in addressing the underlying cause of progressive kidney failure in individuals with primary hyperoxaluria type 1 (PH1). | |||
T26997 |
CGP-28014
|
||
CGP-28014 is an inhibitor of catechol-O-methyltransferase. CGP-28014 increases the renal excretion of both dopamine and dihydroxyphenylacetic acid (DOPAC) but does not affect renal sodium handling indicating a different mechanism of action. CGP-28014 sign | |||
T78069 |
RPR132595A hydrochloride
NPC hydrochloride |
Drug Metabolite | Metabolism |
RPR132595A (NPC) hydrochloride,CPT-11的活性代谢产物,由细胞色素P-450 3A4 (CYP3A4) 催化产生,经尿液排出体外。 | |||
T38062 |
N-acetyl Leukotriene E4
N-acetyl Leukotriene E4 |
||
N-acetyl LTE4 is the major inactive metabolite of LTE4 found in bile. This route of metabolism is prominent in the rat, but of minor importance in humans. N-acetyl LTE4 is 100 times less potent than LTC4 as a vasoconstricting agent. In healthy human subjects urinary excretion of N-acetyl LTE4 is about 1.5 nmol/mol creatinine, which is considerably less than that of LTE4 (12 nmol/mol creatinine). | |||
T37229 |
(±)8,9-DiHETE
|
||
(±)8,9-DiHETE is a major metabolite of the 20:5 ω-3 fatty acid eicosapentaenoic acid .[1] It is produced in rat liver microsomes, but not renal microsomes, by the generation of the unstable intermediate 8,9-epoxy eicosatetraenoic acid from EPA by cytochrome P450 monooxygenases. Dietary EPA supplementation in humans results in substantial urinary excretion of vicinal diols, including 8,9, 11,12, and 14,15 forms.[2] | |||
T61983 |
Trichlormethiazide sodium
|
||
Trichlormethiazide sodium 是口服有效的噻嗪类利尿剂,显示降压活性。在急性肾功能衰竭大鼠中,Trichlormethiazide sodium 可增加尿量、Na 和 K 排泄,并有改善肌酐清除率 (CCRE)。 | |||
T37004 |
Estradiol 3-sulfate 17β-Glucuronide (potassium salt)
|
||
Estradiol 3-sulfate is a sulfated form of the steroid hormone 17β-estradiol , and is common in fetal plasma and in the breast tissues of patients with mammary carcinoma. Sulfated estrogens, including estradiol 3-sulfate, can be converted back to the parent compound by sulfatases. Estradiol 3-sulfate 17β-glucuronide is a metabolite of estradiol 3-sulfate that has been modified by a UDP-glucuronosyltransferase. Glucuronidation of estrogens enhances their utilization by anion transporters, most com... | |||
T36055 |
Nitisinone-13C6
Nitisinone-13C6 |
||
Nitisinone-13C6is intended for use as an internal standard for the quantification of nitisinone by GC- or LC-MS. Nitisinone is an inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), which converts 4-hydroxyphenylpyruvate (HPPA) to homogentisate in the tyrosine catabolic pathway.1Nitisinone increases urinary levels of HPPA and 4-hydroxyphenyllactate (HPLA) in rats when administered at a dose of 10 mg/kg. Nitisinone (3 mg/kg) prevents the neonatal lethality of fumarylacetoacetate hydrolase (F... | |||
T37275 |
2,3-dinor-11β-Prostaglandin F2α
2,3-dinor-11β-Prostaglandin F2α |
||
2,3-dinor-11β-Prostaglandin F2α (2,3-dinor-11β-PGF2α) was recovered from the urine of both normal monkeys and humans when infused with radiolabeled PGD2, where it represented approximately 1% and 4% of the infused radiolabeled dose, respectively. 2,3-dinor-11β-PGF2α has also been recovered from the urine of mastocytosis patients, where it is excreted in large amounts. In human asthmatic patients, 2,3-dinor-11β-PGF2α represents about 40% (as determined by GC/MS) of the immunoreactive 11β-PGF2α wh... | |||
T70390 |
YM-543 choline
|
||
YM-543, also known as ASP-543, is a selective SGLT2 inhibitor. Sodium-glucose cotransporter 2 (SGLT2) is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. YM543 potently and selectively inhibited mouse and human SGLT2 activities at nanomolar ranges. In vivo single oral administration of YM543 dose-dependently and significantly reduced blood glucose level... | |||
T37905 | Hexanoyl Glycine | ||
Hexanoyl glycine is an acylated amino acid that is used as a urinary biomarker for several indications. It is normally biosynthesized from hexanoyl-CoA and glycine by the mitochondrial enzyme glycine N-acyltransferase. Increased urinary excretion of hexanoyl glycine in humans is indicative of a deficiency in medium-chain acyl-CoA dehydrogenase. Increased urinary hexanoyl glycine can also be used as a biomarker for exposure to gamma radiation. Levels of hexanyl glycine can also be elevated during... | |||
T71870 |
CP21
|
||
CP21 is an iron chelator that binds to iron in a 3:1 (ligand:iron) ratio. It is active against P. falciparum when used at concentrations of 10 and 100 µM. CP21 inhibits production of prostaglandin I2 induced by epinephrine, arachidonic acid, or A23187 in isolated rat aortic rings with IC50 values of 1.3, 1.3, and 1.4 mM, respectively. It inhibits glutamate-induced oxytosis, as well as decreases iodoacetic acid-induced cytotoxicity in an in vitro model of ischemia, in HT22 mouse hippocampal cells... | |||
T80890 |
Uroguanylin-15 (Rat)
|
||
Uroguanylin-15 (Rat) 是一种具备调节肾脏钠排泄功能的生物活性肽,尤其在摄入过量氯化钠时发挥作用。它与尿鸟苷蛋白及鸟苷蛋白相关,这两种肽能够激活肠道及肾脏中的鸟苷酸环化酶信号传导分子。尽管从尿液和十二指肠可分离出尿鸟苷素,大鼠结肠的提取物中却未观察到其存在。 | |||
T35890 |
Pentosidine
|
||
Advanced glycation end products (AGEs) are compounds formed by non-enzymatic chemical reactions following the bonding of sugars to proteins or lipids during diabetes, uremia, aging, rheumatic arthritis, and other conditions. A receptor for the AGEs (RAGE) binds certain members of this class to initiate cell signaling.[1][2] Pentosidine is a well-characterized natural AGE that is often used as a biomarker for the production of all AGEs. While pentosidine can be measured in urine, the majority of ... | |||
T38156 |
N-Acetyl-DL-penicillamine
|
||
N-Acetyl-DL-penicillamine is a chelating agent.1,2,3It inhibits the binding of methyl mercury to isolated human erythrocytes by 50% and removes 50% of methyl mercury ions from methyl mercury-loaded blood cells when used at a concentration of 1 mM.1,2N-Acetyl-DL-penicillamine (3 mmol/kg per day, p.o.) reduces the biological half-life of mercury and decreases liver, kidney, brain, and blood mercury levels, as well as increases urinary excretion of mercury in a concentration-dependent manner, in mi... | |||
T78059 |
Glucagon (Human)
Hyperglycemic-glycogenolytic factor,Glukagon |
Others | Others |
Glucagon 对蛋白质和氨基酸的代谢产生显著的调节作用。它抑制了氨基酸与肝脏、肌肉以及胰腺蛋白的结合,增加氮的排出,并促进肝脏内尿素的合成。同时,Glucagon 增加了肝脏中转氨酶和尿素循环酶的浓度,提高了肝脏对氨基酸的摄取,并加强了氨基酸与肝糖原之间的结合,从而降低了血液中的氨基酸浓度。 | |||
T36039 | 16α-Hydroxyestrone | ||
The naturally-occurring estrogens are estrone , estradiol , and estriol . 16α-hydroxy Estrone (16α-OHE1) is a hydroxylated metabolite of E1 as well as an interconversion product with E2. E1 is 16α-hydroxylated by cytochrome P450 (CYP) isoforms, including CYP1A1, CYP3A5, CYP3A4, and CYP3A7, with CYP3A5 being breast-specific. 16α-OHE1 is sulphatized or glucuronidated before excretion. It is increased in rheumatoid arthritis and decreased by physical activity. Unlike the parent estrogens and other ... | |||
T19652 |
IR-825
|
Others | Others |
IR-825 是一种近红外染料。 IR-825 纳米粒子显示出 pH 依赖性荧光发射和对体外靶向癌细胞的出色近红外辐射,以提供细胞毒性。 IR-825 纳米颗粒显示出有效的肿瘤归巢以及快速的肾脏排泄行为,如 MR 成像所揭示并通过生物分布测量得到证实。 | |||
T79177 | URAT1&XO inhibitor 2 | Xanthine Oxidase | Metabolism |
URAT1&XO inhibitor 2 (Compound BDEO)是一种针对xanthine oxidase (黄嘌呤氧化酶) 及URAT1的双重抑制剂,对xanthine oxidase展现出优异的抑制效果,IC50值为3.3 μM。该化合物在表达URAT1的HEK293细胞中显著抑制尿酸的摄取,其Ki值达到0.145 μM。在动物模型中,URAT1&XO inhibitor 2有效降低高尿酸血症小鼠的血清尿酸水平,并增加尿酸的排泄。该化合物主要用于高尿酸血症的研究。 | |||
T36916 |
Estrone-3-Glucuronide (sodium salt hydrate)
|
||
Estrone-3-Glucuronide is a metabolite of the primary premenopausal estrogen 17β-estradiol .1,2Urinary levels of estrone-3-Glucuronide peak approximately 36 hours prior to ovulation and have been used as a marker of fertility in women. 1.Blackwell, L.F., Brown, J.B., and Cooke, D.Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual ... | |||
T35665 |
Pregnanetriol
|
||
Pregnanetriol is a metabolite of 17α-hydroxyprogesterone .1,2It is formed from 17α-hydroxyprogesterone by reduction of the C-20 ketone.2Urinary levels of pregnanetriol are elevated in patients with 21-hydroxylase deficiency and congenital adrenal hyperplasia.3,4 1.Kamrath, C., Hartmann, M.F., Boettcher, C., et al.Diagnosis of 21-hydroxylase deficiency by urinary metabolite ratios using gas chromatography-mass spectrometry analysis: Reference values for neonates and infantsJ. Steroid Biochem. Mol... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2963 |
Cholic Acid
Cholanic acid,胆汁酸,Cholate,Colalin |
Endogenous Metabolite | Metabolism |
Cholic Acid (Cholate) 是肝脏产生的主要胆汁酸,与牛磺酸或甘氨酸缀合,有助于脂肪吸收和胆固醇排泄。 | |||
T4537 |
Cholic acid sodium
胆酸钠,[胆酸钠],SodiumCholate |
HIV Protease; Endogenous Metabolite | Metabolism; Microbiology/Virology; Proteases/Proteasome |
Cholic acid sodium (SodiumCholate) 是肝脏中产生的主要胆汁酸,通常与牛磺酸或甘氨酸结合,有助于脂肪吸收和胆固醇排泄。 | |||
T0613 |
3-Hydroxyisovaleric acid
β-羟基异戊酸,Beta-Hydroxyisovaleric acid |
Others; Endogenous Metabolite | Metabolism; Others |
3-Hydroxyisovaleric acid (Beta-Hydroxyisovaleric acid) 是尿液中排泄的内源性代谢产物 ,可作为生物素缺乏的早期和敏感指标。 | |||
T5246 |
Trans-2-butene-1,4-dicarboxylic acid
trans-2-Butene-1,4-dicarboxylic Acid,3-Hexenedioic Acid,trans-3-Hexenedioic Acid,β-Hydromuconic Acid,反式-2-丁烯-1,4-二甲酸 |
Others; Endogenous Metabolite | Metabolism; Others |
Trans-2-butene-1,4-dicarboxylic acid (3-Hexenedioic Acid) 是内源性代谢产物的一种。 | |||
T0737 |
L-Ornithine
(S)-2,5-Diaminopentanoic acid,L-鸟氨酸,鸟氨酸 |
Decarboxylase; Amino Acids and Derivatives; Arginase; Endogenous Metabolite | Immunology/Inflammation; Metabolism; Others |
L-Ornithine ((S)-2,5-Diaminopentanoic acid) 具有抗疲劳作用,能够促进氨的排泄和提高能量消耗效率。 | |||
T4831 |
α,α-Dimethylglycine
2-Aminoisobutyric acid,α-Aminoisobutanoic acid,2-甲基丙氨酸 |
Others; Endogenous Metabolite | Metabolism; Others |
NSC-16590 (2-Aminoisobutyric acid) 对苍耳子叶中内源性乙烯(ethylene)的产生具有抑制作用。 | |||
T2O2701 |
L-Ornithine hydrochloride
L(+)-Ornithine hydrochloride,(S)-2,5-Diaminopentanoic acid,L-鸟氨酸盐酸盐;L-2,5-二氨基戊酸盐酸盐;L-鸟氨酸单盐酸盐;鸟氨酸盐酸盐;L-盐酸鸟氨酸;L-鸟粪氨基酸盐酸盐 |
Others; Endogenous Metabolite | Metabolism; Others |
L-Ornithine hydrochloride ((S)-2,5-Diaminopentanoic acid) 通过提高能量消耗效率和促进氨的排泄而具有抗疲劳作用。它是尿素循环中的关键反应物之一。 | |||
T0983 |
Penicillamine
青霉胺,d-penicillamin,Dimethyl Cysteine,D-青霉胺,Artamine,D-(-)-Penicillamine |
Antibiotic | Microbiology/Virology |
Penicillamine (Artamine) 是一种 penicillin 的代谢降解产物,是一种螯合剂,可作用于威尔逊氏病。 | |||
T1614 |
Hydrocortisone
氢化可的松,Cortisol |
Glucocorticoid Receptor; Endogenous Metabolite | Endocrinology/Hormones; Metabolism |
Hydrocortisone (Cortisol) 是一种糖皮质激素,由肾上腺素皮质分泌。Hydrocortisone 激动糖皮质激素受体,可促进蛋白质分解代谢、糖异生、毛细血管壁稳定性、肾脏钙排泄,并抑制免疫和炎症反应。 | |||
T5233 |
N-Methylnicotinamide
N'-Methylnicotinamide,Nicotinic Acid Methylamide,N-Methylpyridine-3-carboxamide,N-甲基烟酰胺 |
Others; Endogenous Metabolite | Metabolism; Others |
N-Methylnicotinamide (Nicotinic Acid Methylamide) 是内源性代谢产物的一种。 | |||
T4858 |
4-Hydroxyphenylpyruvic acid
4-羟苯基丙酮酸,4-Hydroxyphenylpyruvic acid |
Endogenous Metabolite | Metabolism |
4-Hydroxyphenylpyruvic acid 是一种苯丙氨酸代谢的中间产物,是一种酶抑制剂。 | |||
T5215 |
N-(3-Phenylpropionyl)glycine
N-(3-苯基丙酰基)甘氨酸,Phenylpropionylglycine |
Others | Others |
N-(3-Phenylpropionyl)glycine (Phenylpropionylglycine) 是一种酰基甘氨酸。酰基甘氨酸通常是脂肪酸的次要代谢物。 | |||
T5245 |
N-Isovaleroylglycine
N-异戊酰氨基乙酸,Isovaleroylglycine,N-Isovalerylglycine |
Others; Endogenous Metabolite | Metabolism; Others |
N-Isovaleroylglycine (Isovaleroylglycine) 是酰基甘氨酸,能够作为体重提高和肥胖的生物标记物。 | |||
T5S0053 |
Coptisine
黄连碱,Coptisin |
Indoleamine 2,3-Dioxygenase (IDO) | Metabolism |
Coptisine (Coptisin) 是一种从黄连中分离到的生物碱,是非竞争性的IDO 抑制剂,Ki=为 5.8 μM,IC50=6.3 μM。 | |||
T4716 |
Pyrrole-2-carboxylic acid
吡咯-2-羧酸,2-Pyrrolecarboxylic acid,Minaline |
Endogenous Metabolite | Metabolism |
Pyrrole-2-carboxylic acid (Minaline) 是一种天然生物碱类,从海洋细菌Pelomonas puraquaesp. Nov 中分离得到。 | |||
T38954 |
L-Glyceric acid sodium
|
||
L-Glyceric acid sodium is a urinary metabolite predominantly found in individuals with the rare inherited metabolic disorder, L-glyceric aciduria. This compound serves as a diagnostic tool for identifying primary hyperoxaluria type 2 (PH2) and can be used to differentiate between PH1 and PH2 based on its excretion pattern. | |||
T75427 | Cholic acid sodium hydrate | ||
Cholic acid sodium hydrate, 为肝脏主要产生的胆汁酸,常与甘氨酸或牛磺酸结合,促进脂肪吸收及胆固醇排出,具备口服活性。 | |||
T74293 |
Allolithocholic acid
|
||
Allolithocholic acid 是一种类固醇酸,在正常血清和粪便中可发现。该化合物促进脂肪与甾醇在肠道及肝脏的排泄、吸收与运输。 | |||
T36472 |
Tetrahydro-11-deoxy Cortisol
|
||
Tetrahydro-11-deoxy cortisol (THS) is the primary urinary metabolite of 11-deoxycortisol. Urinary excretion of THS is elevated in patients with 11β-hydroxylase deficiency, a condition resulting from mutations in the cytochrome P450 (CYP) isoform CYP11B1. Urinary levels of THS are also elevated in patients with adrenocortical carcinoma (ACC) and adrenocortical adenoma (ACA) but are higher in patients with ACC compared to ACA. |